# A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma

> **NCT03693807** · PHASE2 · COMPLETED · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 35 (actual)

## Conditions studied

- Colorectal Cancer
- Cholangiocarcinoma

## Interventions

- **DEVICE:** Medtronic pump and Codman catheter
- **DRUG:** Floxuridine (FUDR)
- **DRUG:** Gemcitabine
- **DRUG:** Oxaliplatin
- **DRUG:** Irinotecan (CPT-11)
- **DRUG:** Fluorouracil
- **DRUG:** Anti-EGFR (Panitumumab or Cetuximab)

## Key facts

- **NCT ID:** NCT03693807
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-10-18
- **Primary completion:** 2024-06-27
- **Final completion:** 2024-06-27
- **Target enrollment:** 35 (ACTUAL)
- **Last updated:** 2026-02-06


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03693807

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03693807, "A Study of the Use of the Medtronic Pump and Codman Catheter to Give Chemotherapy to Patients With Colorectal Carcinoma or Cholangiocarcinoma". Retrieved via AI Analytics 2026-07-13 from https://api.ai-analytics.org/clinical/NCT03693807. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*